Expertise in
10
conditions

Dorota M. Krasowska

Staszica 11 St, 
Lublin, LU, PL 
Expertise in
10
conditions
Staszica 11 St, 
Lublin, LU, PL 

Overview

Dorota Krasowska practices practicing medicine in Lublin, Poland.

Ms. Krasowska is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Hives, Systemic Sclerosis (SSc), Chronic Spontaneous Urticaria (CSU), and Synovectomy.

She is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Staszica 11 St, Lublin, LU 20081, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 2 Less Clinical Trials

139 Total Publications

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.
Journal: Allergy
Published: October 15, 2025

Frequently Asked Questions about Dorota M. Krasowska

Is Dorota M. Krasowska a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Dorota M. Krasowska is classified as an Distinguished expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dorota M. Krasowska participate in research or clinical trials?

Yes. Dorota M. Krasowska has published 139 articles and abstracts on conditions like Scleroderma. You can view a list of Dorota M. Krasowska's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Krasowska's expertise for a condition
ConditionClose
    View All 48 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile